The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 11, 2021
Filed:
Feb. 06, 2017
Applicants:
Orionis Biosciences Bv, Ghent, BE;
Vib Vzw, Ghent, BE;
Universiteit Gent, Ghent, BE;
Inventors:
Jan Tavernier, Balegem, BE;
Nikolai Kley, Newton, MA (US);
Anje Cauwels, Merelbeke, BE;
Sarah Gerlo, Ghent, BE;
Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 14/715 (2006.01); C07K 16/24 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); C07K 16/00 (2006.01); C07K 14/56 (2006.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2815 (2013.01); A61K 38/00 (2013.01); A61K 39/395 (2013.01); A61P 35/00 (2018.01); C07K 14/56 (2013.01); C07K 14/7156 (2013.01); C07K 16/00 (2013.01); C07K 16/249 (2013.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); C07K 16/2851 (2013.01); C07K 16/2887 (2013.01); A61K 2039/505 (2013.01); A61K 2039/57 (2013.01); C07K 2317/22 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/569 (2013.01); C07K 2317/622 (2013.01); C07K 2317/66 (2013.01); C07K 2317/74 (2013.01); C07K 2317/90 (2013.01); C07K 2317/92 (2013.01); C07K 2319/00 (2013.01); C07K 2319/02 (2013.01); C07K 2319/33 (2013.01); C07K 2319/735 (2013.01); C07K 2319/74 (2013.01); Y02A 50/30 (2018.01);
Abstract
The present invention relates, in part, to agents that bind Clec9A and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the Clec9A binding agents and their use in the treatment of various diseases.